Evolus Inc (NASDAQ: EOLS) kicked off on Friday, up 1.26% from the previous trading day, before settling in for the closing price of $9.56. Over the past 52 weeks, EOLS has traded in a range of $8.67-$17.82.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 51.00% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 23.26%. With a float of $56.92 million, this company’s outstanding shares have now reached $64.45 million.
In an organization with 332 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 67.73%, operating margin of -14.2%, and the pretax margin is -20.19%.
Evolus Inc (EOLS) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Evolus Inc is 11.72%, while institutional ownership is 84.45%. The most recent insider transaction that took place on May 12 ’25, was worth 33,397. In this transaction an insider of this company sold 3,385 shares at a rate of $9.87, taking the stock ownership to the 359,082 shares. Before that another transaction happened on May 13 ’25, when Company’s Chief Financial Officer sold 6,494 for $10.02, making the entire transaction worth $65,070. This insider now owns 167,089 shares in total.
Evolus Inc (EOLS) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 23.26% per share during the next fiscal year.
Evolus Inc (NASDAQ: EOLS) Trading Performance Indicators
Take a look at Evolus Inc’s (EOLS) current performance indicators. Last quarter, stock had a quick ratio of 2.16. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.89, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach 0.57 in one year’s time.
Technical Analysis of Evolus Inc (EOLS)
Let’s dig in a bit further. During the last 5-days, its volume was 0.76 million. That was inferior than the volume of 0.9 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 17.58%. Additionally, its Average True Range was 0.60.
During the past 100 days, Evolus Inc’s (EOLS) raw stochastic average was set at 11.95%, which indicates a significant increase from 10.16% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 67.74% in the past 14 days, which was lower than the 72.74% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.16, while its 200-day Moving Average is $13.35. However, in the short run, Evolus Inc’s stock first resistance to watch stands at $9.78. Second resistance stands at $9.87. The third major resistance level sits at $10.04. If the price goes on to break the first support level at $9.51, it is likely to go to the next support level at $9.34. Assuming the price breaks the second support level, the third support level stands at $9.25.
Evolus Inc (NASDAQ: EOLS) Key Stats
The company with the Market Capitalisation of 624.12 million has total of 64,476K Shares Outstanding. Its annual sales at the moment are 266,270 K in contrast with the sum of -50,420 K annual income. Company’s last quarter sales were recorded 68,520 K and last quarter income was -18,890 K.
